David Buck

Stock Analyst at B. Riley Securities

(0.25)
# 4,478
Out of 4,789 analysts
14
Total ratings
21.43%
Success rate
-27.2%
Average return

Stocks Rated by David Buck

MediciNova
Mar 25, 2019
Assumes: Buy
Price Target: $22
Current: $1.45
Upside: +1,417.24%
Supernus Pharmaceuticals
Nov 12, 2018
Maintains: Buy
Price Target: $68$65
Current: $31.68
Upside: +105.18%
Jazz Pharmaceuticals
Nov 8, 2018
Maintains: Buy
Price Target: $219$190
Current: $124.99
Upside: +52.01%
Amneal Pharmaceuticals
Aug 22, 2018
Maintains: Buy
Price Target: $26$28
Current: $8.23
Upside: +240.22%
Alkermes
Jun 6, 2018
Initiates: Buy
Price Target: $60
Current: $32.53
Upside: +84.45%
Evoke Pharma
Oct 19, 2017
Reinstates: Buy
Price Target: $1,440
Current: $2.51
Upside: +57,270.52%